Bonesupport Holding AB (BONEX)

Currency in SEK
328.60
+8.80(+2.75%)
Real-time Data·
Advertisement
Unusual trading volume
Trading near 52-week High
BONEX is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
311.80331.00
52 wk Range
165.00331.00
Key Statistics
Prev. Close
319.8
Open
317
Day's Range
311.8-331
52 wk Range
165-331
Volume
735.23K
Average Volume (3m)
309.24K
1-Year Change
37.8356%
Book Value / Share
14.50
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BONEX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
357.42
Upside
+8.77%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Bonesupport Holding AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 357.42
(+8.77% Upside)

Bonesupport Holding AB Earnings Call Summary for Q3/2026

  • Q3 net sales surged 39% to SEK 409M with adjusted operating margin of 34%; stock jumped 16.33% to $299.2 in pre-market trading.
  • SOLARIO study in New England Journal of Medicine supports reduced systemic antibiotic use, potentially expanding local therapy adoption.
  • New U.S. CMS inpatient reimbursement ruling effective Oct. 1 expected to benefit revenue gradually as hospitals adopt new billing practices.
  • Company maintains 2026 guidance of 33-36% sales growth at constant currencies; CERAMENT V FDA decision expected Q4 2026 or Q1 2027.
  • Gross margin declined to 94% from 95.3% due to higher manufacturing costs and tariffs; operating leverage improved despite commercial investments.
Last Updated: 22/10/2026, 10:32
Read Full Transcript

Earnings

Latest Release
22/10/2026
EPS / Forecast
1.40 / 1.26
Revenue / Forecast
408.8M / 389.95M
EPS Revisions
Last 90 days

Compare BONEX to Peers and Sector

Metrics to compare
BONEX
Peers
Sector
Relationship
P/E Ratio
100.5x−6.4x−0.3x
PEG Ratio
2.25−0.120.00
Price/Book
22.6x2.3x2.6x
Price / LTM Sales
16.7x21.5x2.9x
Upside (Analyst Target)
9.1%311.4%64.3%
Fair Value Upside
Unlock16.7%9.2%Unlock

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Employees
171
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
16.17M24.70%4.16B
Other Institutional Investors
25.32M38.67%6.51B
Public Companies & Retail Investors
23.99M36.63%6.17B
Total
65.49M100.00%16.84B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Swedbank Robur Fonder AB9.22%6,035,4971,552,330
SMALLCAP World Fund, Inc.5.30%3,469,136892,262

People Also Watch

22.95
LBIRD
-1.08%
77.15
HEM
-5.10%
335.80
SECTb
+0.30%
13.130
EUZG
-1.28%
218.60
LAGRb
-2.76%

FAQ

What Is the Bonesupport (Stockholm: BONEX) Share Price Today?

The Bonesupport stock price today is 328.60 SEK.

What Stock Exchange Does Bonesupport (BONEX) Trade On?

Bonesupport is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Bonesupport?

The stock symbol (also called a 'ticker') for Bonesupport is "BONEX."

What Is the Current Bonesupport Market Capitalisation?

As of today, Bonesupport (Stockholm: BONEX) market cap is 21.53B SEK.

What Is Bonesupport's (BONEX) Earnings Per Share (TTM)?

The Bonesupport EPS is currently 3.24 (Trailing Twelve Months).

When Is the Next Bonesupport Earnings Date?

Bonesupport's next earnings report will be released on 18/02/2027.

Is BONEX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bonesupport moving averages and other technical indicators, the daily buy/sell signal for BONEX stock is Strong Buy.

How Many Times Has Bonesupport Stock Split?

Bonesupport has split 0 times. (See the BONEX stock split history page for full effective split date and price information.)

How Many Employees Does Bonesupport Have?

Bonesupport has 171 employees, based on their latest Companies House report.

What is the current trading status of Bonesupport (Stockholm: BONEX)?

As of 23/10/2026, Bonesupport (BONEX) is trading at a share price of 328.60 SEK, with a previous close of 319.80 SEK. The stock has fluctuated within a day range of 311.80 SEK to 331.00 SEK, while its 52-week range spans from 165.00 SEK to 331.00 SEK.

What Is Bonesupport (BONEX) Price Target According to Analysts?

The average 12-month price target for Bonesupport is 357.42 SEK, with a high estimate of 416 SEK and a low estimate of 280 SEK. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +8.77% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.